GENERAL Natco Launches Generic Carboplatin Injection In US For Cancer Treatment

Natco Pharma Ltd has launched Carboplatin Injection, a generic version of Paraplatin, in the US market through its US subsidiary Natco Pharma USA LLC, targeting a market with estimated annual sales of $27.8 million. The Hyderabad-based pharmaceutical company has launched the product in manufacturing collaboration with Chennai-based Teyro Labs Pvt Ltd. The launch is expected […]

CW Bureau · Oct 19, 2026

GENERAL Pharma Sector Revenue Growth Seen At 11-13% This Fiscal: Crisil Ratings

India’s pharmaceutical sector is expected to see revenue growth accelerate to 11-13% this fiscal from 8% last fiscal, supported by stronger exports and firmer domestic demand, according to Crisil Ratings. However, the improvement in revenue is unlikely to translate fully into earnings as higher raw material, energy and freight costs are expected to put pressure […]

CW Bureau · Sep 24, 2026

GENERAL Dr Reddy’s To Distribute Takeda’s QDENGA Dengue Vaccine In India

Dr Reddy’s Laboratories and Takeda Pharmaceutical Company, through its Indian subsidiary Takeda Biopharmaceuticals India Pvt Ltd, have entered into a distribution agreement under which Dr Reddy’s will promote and distribute Takeda’s dengue vaccine QDENGA across India’s private market for pediatric and adult vaccination. Subject to completion of applicable processes with local authorities, QDENGA is expected […]

CW Bureau · Sep 18, 2026

GENERAL Gland Pharma Set To Acquire Gland Pharma USA In A $5.01-Lakh Deal

Gland Pharma Ltd has approved the acquisition of 100% equity in Gland Pharma USA Inc. (Gland US), a wholly-owned step-down subsidiary, from Gland Pharma International Pte. Ltd., a wholly-owned subsidiary, for $5.01 lakh. Upon completion of the transaction, Gland US will become a direct wholly-owned subsidiary of Gland Pharma. The company expects to complete the […]

CW Bureau · Sep 13, 2026

STARTUP/TECHNOLOGY RPG Life Sciences Arm To Acquire Raghava Life Sciences API For ₹135 Cr

RPG Life Sciences Ltd’s wholly owned subsidiary RPG Active Pharma Ltd (RPGAP) has entered into a Business Transfer Agreement to acquire the Active Pharmaceutical Ingredients (API) and intermediates business of Raghava Life Sciences Pvt Ltd for ₹135 crore. The business will be acquired on a going-concern basis through a slump sale. The transaction is part […]

CW Bureau · Sep 3, 2026

GENERAL Sun Pharmaceutical Agrees To MFN Pricing For US Medicaid Programmes

Sun Pharmaceutical Industries has joined several pharmaceutical companies in announcing agreements with the US government aimed at prioritising access to affordable medicines for millions of American patients. Under its agreement, Sun Pharma will extend Most Favoured Nation (MFN) pricing to state Medicaid programmes. The company has also committed to MFN pricing for future innovative medicine […]

CW Bureau · Sep 1, 2026

GENERAL Biocon Biologics Secures Japan Govt Approval For Pegfilgrastim Biosimilar

Biocon Biologics Ltd, a wholly owned subsidiary of Biocon Ltd., has received marketing approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for its pegfilgrastim biosimilar, strengthening the company’s biosimilars portfolio in the Japanese market. The product is a biosimilar to Neulasta, a pegfilgrastim-based medicine used to reduce the risk of infection associated with […]

CW Bureau · Aug 25, 2026

GENERAL Piramal Pharma Acquires Additional 40.67% Stake In Yapan Bio For ₹76 Cr

Piramal Pharma Ltd has completed the acquisition of an additional 40.67% stake in Yapan Bio Pvt Ltd for ₹76 crore, taking its total holding in the Hyderabad-based company to 74%. With the completion of the transaction on August 18, Yapan Bio has become a subsidiary of Piramal Pharma. The company is a contract development and […]

CW Bureau · Aug 19, 2026

STARTUP/TECHNOLOGY Amgen To Set Up Science And Innovation Centre In Hyderabad

Hyderabad-based Amgen has announced plans to establish a new Science and Innovation Centre at Genome Valley in Hyderabad. The centre will become part of Amgen’s global Research and Development network, which comprises seven research laboratories. It will expand the company’s scientific and research capabilities in India. Centre to focus on advanced research The new facility […]

CW Bureau · Aug 12, 2026

GENERAL Amneal Pharma Completes Kashiv Bio Buy, Strengthens Biosimilars Platform

Amneal Pharmaceuticals Inc. has completed its acquisition of Kashiv BioSciences LLC, creating a fully integrated global biosimilars platform with capabilities spanning research, development, manufacturing and commercialisation. The acquisition brings together Kashiv’s biologics research, development and manufacturing capabilities with Amneal’s commercial scale, positioning biosimilars as a major long-term growth pillar for the company’s affordable medicines business. […]

CW Bureau · Aug 11, 2026

GENERAL Aurobindo Pharma Signs Licensing Agreement With MSD For HIV Drug

Aurobindo Pharma Ltd  has entered into a non-exclusive voluntary licensing agreement with MSD (the trade name of Merck & Co., Inc., Rahway, New Jersey, USA) to manufacture and supply a generic version of the investigational HIV prevention medicine, Alimatravir, in eligible low- and middle-income countries. Aurobindo Pharma is among a select group of global generic […]

CW Bureau · Jul 25, 2026

GENERAL US FDA Expands Glenmark RYALTRIS Approval To Children Above 6 Years

Glenmark Specialty S A has received approval from the US Food and Drug Administration (US FDA) to expand the use of its allergy treatment RYALTRIS nasal spray for pediatric patients aged 6 to less than 12 years suffering from Seasonal Allergic Rhinitis (SAR). The approval broadens the eligible patient population for the drug in the […]

CW Bureau · Jul 21, 2026